Novel Interactive Cell-phone tech for Health Enhancement
用于增强健康的新型互动手机技术
基本信息
- 批准号:6932631
- 负责人:
- 金额:$ 15.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2006-03-31
- 项目状态:已结题
- 来源:
- 关键词:behavioral /social science research tagblood glucosebody compositionbody physical activityclinical researchclinical trialscomputer assisted patient carecost effectivenessdiabetes educationhealth care service evaluationhealth services research taghuman subjecthuman therapy evaluationnoninsulin dependent diabetes mellitusoutpatient carepatient care managementpatient care personnel relationspatient monitoring devicepatient oriented researchsatisfactionself caretechnology /technique developmenttelemedicinetherapy compliance
项目摘要
The burden of chronic disease in the United States is formidable, with 70% of all deaths attributable to some form of chronic illness. As the majority of chronic diseases arise from, and vary in severity with, modifiable behaviors, self-care has enormous potential to ameliorate their course; however, adherence to self-care plans is often poor. Advances in technology can empower patients in novel ways to adhere to self-care management plans. The Palaistra System is a breakthrough wireless remote patient monitoring and response system that collects and transmits patient data and provides daily interactive, individually tailored informative messages, based on patient data, via cellular phones. Adoption and maintenance of recommended lifestyle changes and disease monitoring/management practices are thus facilitated. Proposed, therefore, is Novel Interactive Cell-phone technology for Health Enhancement (NICHE), a controlled clinical trial evaluating the feasibility and efficacy of the Palaistra System in the management of type 2 diabetes in adults. Feasibility outcomes of this Phase I STTR trial are success of implementation in a clinical setting and validated measures of patient and clinician satisfaction. Clinical and disease-specific outcomes include: HbA1c levels, BMI, physical activity levels, diabetes self-care knowledge and self-efficacy.
在美国,慢性病的负担是巨大的,70%的死亡可归因于某种形式的慢性病。由于大多数慢性病都是由可改变的行为引起的,并且严重程度各不相同,因此自我护理具有改善其病程的巨大潜力;然而,对自我护理计划的坚持往往很差。技术的进步可以使患者以新的方式坚持自我护理管理计划。Palaistra系统是一个突破性的无线远程患者监测和响应系统,它收集和传输患者数据,并通过蜂窝电话提供基于患者数据的每日交互式、个性化定制的信息消息。因此,促进采用和维持建议的生活方式改变和疾病监测/管理做法。因此,提出了一种新的交互式手机健康增强技术(NICHE),这是一项对照临床试验,旨在评估Palaistra系统在成人2型糖尿病管理中的可行性和有效性。这项I期STTR试验的可行性结果是在临床环境中成功实施,并验证了患者和临床医生满意度的测量结果。临床和疾病特异性结局包括:HbA 1c水平、BMI、体力活动水平、糖尿病自我护理知识和自我效能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jamie Jackson其他文献
Jamie Jackson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jamie Jackson', 18)}}的其他基金
Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention
确定先天性心脏病体力活动生活方式干预的功效
- 批准号:
10709643 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention
确定先天性心脏病体力活动生活方式干预的功效
- 批准号:
10586778 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
Physical Activity Lifestyle Intervention for Emerging Adults with Congenital Heart Disease
对患有先天性心脏病的新兴成年人进行体力活动生活方式干预
- 批准号:
9809245 - 财政年份:2019
- 资助金额:
$ 15.44万 - 项目类别:
Self-Management and Transition among Adolescents and Young Adults with Congenital Heart Disease
先天性心脏病青少年和年轻人的自我管理和过渡
- 批准号:
9109769 - 财政年份:2016
- 资助金额:
$ 15.44万 - 项目类别:
相似海外基金
Investigating the blood glucose lowering effect of exogenous ketone ingestion in people with type 2 diabetes
研究外源性酮摄入对 2 型糖尿病患者的降血糖作用
- 批准号:
MR/Y008804/1 - 财政年份:2024
- 资助金额:
$ 15.44万 - 项目类别:
Research Grant
G6PC Enzymology, Structure, Function and Role in the Regulation of Fasting Blood Glucose
G6PC 酶学、结构、功能及其在空腹血糖调节中的作用
- 批准号:
10584866 - 财政年份:2023
- 资助金额:
$ 15.44万 - 项目类别:
Separate extraction of spatial features related to blood glucose level variation from multi-wavelength spectral face images
从多波长光谱人脸图像中单独提取与血糖水平变化相关的空间特征
- 批准号:
23K17258 - 财政年份:2023
- 资助金额:
$ 15.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Glucowear: A non-invasive, wearable, real time continuous blood glucose monitoring sensor
Glucowear:一种非侵入式、可穿戴式、实时连续血糖监测传感器
- 批准号:
10068829 - 财政年份:2023
- 资助金额:
$ 15.44万 - 项目类别:
EU-Funded
A Serious Game to Teach Early School-Aged Children Blood Glucose Monitoring
教早期学龄儿童血糖监测的严肃游戏
- 批准号:
571894-2022 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
University Undergraduate Student Research Awards
Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System
使用基于人工智能的新型血糖控制系统演示重症监护病房中血糖闭环控制的可行性
- 批准号:
10482483 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
GLUMON:Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing
GLUMON:使用非侵入性光声传感的下一代血糖监测
- 批准号:
10032702 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
EU-Funded
Portable Thermophotonic Biosensor Development for in-vivo Blood Glucose Monitoring
用于体内血糖监测的便携式热光子生物传感器的开发
- 批准号:
572588-2022 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
University Undergraduate Student Research Awards
Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System
使用基于人工智能的新型血糖控制系统演示重症监护病房中血糖闭环控制的可行性
- 批准号:
10631190 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
Development of perioperative blood glucose control methods for prevention of postoperative vascular endothelial glycocalyx disorders
开发围手术期血糖控制方法以预防术后血管内皮糖萼疾病
- 批准号:
22K09093 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)